Aug 24 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* FY REVENUE FROM ORDINARY ACTIVITIES $530.3 MILLION VERSUS $572.6 MILLION
* FY LOSS ATTRIBUTABLE $92.4 MILLION VERSUS PROFIT $71.1 MILLION
* NO FINAL DIVIDEND IN RESPECT OF FINANCIAL YEAR ENDED 30 JUNE